Shane Christensen

A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents

Derek Muse, Shane Christensen, Prakash Bhuyan et al. · The Pediatric Infectious Disease Journal · 2016 · 40 citations

A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United States

Lee-Jah Chang, James Hedrick, Shane Christensen et al. · Vaccine · 2020 · 38 citations · Full text

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

Germán Áñez, James Hedrick, Michael Simon et al. · Human Vaccines & Immunotherapeutics · 2020 · 30 citations · Full text

Immunodeficiencies, Immunology, Immunodominance +19

Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to 1 Year After Immunization With a Pandemic A/H1N1 Influenza Vaccine in Children 3 to <9 Years of Age

Cynthia Nassim, Shane Christensen, Dan Henry et al. · The Pediatric Infectious Disease Journal · 2012 · 29 citations

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study

Carmen Baccarini, Michael Simon, Donald M. Brandon et al. · The Pediatric Infectious Disease Journal · 2020 · 23 citations · Full text